Adolescent Health in Myanmar
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Our dynamic, interdisciplinary team works at the forefront of optimising maternal and child health, nutrition and infectious disease programs.
We use our models to generate scientific evidence to guide policy decisions across a range of public health issues, including:
In close partnership with the World Bank we have developed a collection of ‘Optima’ models to link interventions and their costs with their impact, perform scenario analyses, predict epidemiological trends and optimise spending.
Optima tools have already been used by over 40 countries across Eastern Europe, Asia, South America, and Africa to guide resource allocation towards the most cost-effective mix of programs, and to assist with national strategic and operational planning.
COVASIM: Modelling COVID-19
Decision science using Optima
HCV Elimination Modelling
Healthy Mothers, Healthy Babies
HMHB - Health Services for Postnatal and Infancy Care
SimDrink: Using simulation modelling to perform alcohol policy experiments
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
Anna Roberts
Executive Business & Programs Manager, Optima Consortium for Decision Science
Anna Palmer
Research Assistant
Chris Seaman
PhD Student
Professor David Wilson
Head of Infectious Disease Modelling
Doctor Debra ten Brink
Research Assistant
Dominic Delport
Research Assistant
Doctor Katherine Heath
Research Officer
Doctor Nick Scott
Econometrician
Doctor Rachel Sacks-Davis
Research Officer
Doctor Sherrie Kelly
Applications Team Lead
Tom Tidhar
Research Assistant
Tom Walsh
Health Modeller
Translating research into sustainable health solutions for vulnerable communities through health system strengthening, improved health service delivery and empowering communities.
Supporting national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.
There is an unmet need for new and/or improved tests for many diseases that predominantly affect disadvantaged populations.
Discovery of new drug targets for antiretroviral therapy and prevention.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2020 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
